110 related articles for article (PubMed ID: 2089265)
1. Lipid changes in central nervous system membranes in experimental allergic encephalomyelitis (EAE).
Salvati S; Attorri L; Confaloni A; Di Biase A
Neurochem Res; 1990 Nov; 15(11):1051-3. PubMed ID: 2089265
[TBL] [Abstract][Full Text] [Related]
2. Biochemical changes in central nervous system membranes in chronic-relapsing experimental allergic encephalomyelitis.
Salvati S; Confaloni A; DiBiase A; Attorri L; Serlupi Crescenzi G
Mol Chem Neuropathol; 1990 Jun; 12(3):229-41. PubMed ID: 2091667
[TBL] [Abstract][Full Text] [Related]
3. Biochemical changes in central nervous system membranes in experimental allergic encephalomyelitis.
Salvati S; D'Urso D; Conti Devirgiliis L; Serlupi Crescenzi G
J Neurochem; 1986 Jul; 47(1):239-44. PubMed ID: 3011992
[TBL] [Abstract][Full Text] [Related]
4. Role of lipid interactions in autoimmune demyelination.
Ohler B; Graf K; Bragg R; Lemons T; Coe R; Genain C; Israelachvili J; Husted C
Biochim Biophys Acta; 2004 Jan; 1688(1):10-7. PubMed ID: 14732476
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat.
Zaprianova E; Deleva D; Filchev A
Neurochem Res; 1998 Nov; 23(11):1421-5. PubMed ID: 9814553
[TBL] [Abstract][Full Text] [Related]
6. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system lipid alterations in rats with experimental allergic encephalomyelitis and its suppression by immunosuppressive drugs.
Roth GA; Monferran CG; Maggio B; Cumar FA
Life Sci; 1982 Mar; 30(10):859-66. PubMed ID: 7200180
[TBL] [Abstract][Full Text] [Related]
8. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis.
Slavin DA; Bucher AE; Degano AL; Soria NW; Roth GA
Neurochem Int; 1996 Dec; 29(6):597-605. PubMed ID: 9113127
[TBL] [Abstract][Full Text] [Related]
9. Experimental allergic encephalomyelitis. Identification of the myelin component responsible for the appearance of brain esterified cholesterol.
Roth GA; Maggio B; Monferrán CG; Cumar FA
FEBS Lett; 1978 Feb; 86(1):29-32. PubMed ID: 413746
[No Abstract] [Full Text] [Related]
10. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE).
Inuzuka T; Sato S; Baba H; Miyatake T
Neurochem Res; 1988 Mar; 13(3):225-8. PubMed ID: 2455235
[TBL] [Abstract][Full Text] [Related]
12. Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis.
Seil FJ; Smith ME; Leiman AL; Kelly JM
Science; 1975 Mar; 187(4180):951-3. PubMed ID: 49925
[TBL] [Abstract][Full Text] [Related]
13. Hyperphenylalaninaemia and experimental allergic encephalomyelitis.
Mertin J; Hunt R
J Neurol Sci; 1976 Oct; 29(2-4):351-9. PubMed ID: 978215
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens.
Chalk JB; McCombe PA; Smith R; Pender MP
J Neurol Sci; 1994 May; 123(1-2):154-61. PubMed ID: 7520480
[TBL] [Abstract][Full Text] [Related]
15. Baisc protein hydrolysis in lymphocytes of Lewis rats with experimental allergic encephalomyelitis.
SMith ME
Adv Exp Med Biol; 1978; 100():347-63. PubMed ID: 80945
[TBL] [Abstract][Full Text] [Related]
16. Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis.
Selivonchick DP; Johnston PV
J Nutr; 1975 Mar; 105(3):288-300. PubMed ID: 1117339
[TBL] [Abstract][Full Text] [Related]
17. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination.
Shields DC; Banik NL
Brain Res; 1998 May; 794(1):68-74. PubMed ID: 9630523
[TBL] [Abstract][Full Text] [Related]
19. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte Plasma Membrane Lipid Composition Mirrors That of Neurons and Glial Cells in Murine Experimental In Vitro and In Vivo Inflammation.
Stanzani A; Sansone A; Brenna C; Baldassarro VA; Alastra G; Lorenzini L; Chatgilialoglu C; Laface I; Ferreri C; Neri LM; Calzà L
Cells; 2023 Feb; 12(4):. PubMed ID: 36831228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
